Climacteric Syndrome
8
1
1
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
25%
2 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (8)
Pharmacokinetic Aspects of 25-mg Estradiol Pellet in Climacteric Women
Multimodal Program for Climacteric Women
Effects of Combined Natural Molecules on Metabolic Syndrome in Menopausal Women
The Effects of Luo-Bu-Fu-Ke-Bi-RI Pill
Clinical Evaluation of Effectiveness and Safety of Amberen and Smart B by Women With Climacteric Syndrome
Efficacy and Safety of Passiflora Incarnata and Isoflavona Combination in the Treatment of Climacteric Symptoms
Efficiency of Placental Drug Melsmon® in Correction of Climacteric Symptoms in Premenopausal Women
Effectiveness and Safety of Acupuncture for Climacteric Syndrome in Patients With Breast Cancer